Follow
Enya Ong
Enya Ong
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Prognostic model for stratification of radioresistant nasopharynx carcinoma to curative salvage radiotherapy
YQ Li, YM Tian, SH Tan, MZ Liu, G Kusumawidjaja, EHW Ong, C Zhao, ...
Journal of Clinical Oncology 36 (9), 891-899, 2018
982018
Comparison of radiomics tools for image analyses and clinical prediction in nasopharyngeal carcinoma
ZG Liang, HQ Tan, F Zhang, LK Rui Tan, L Lin, J Lenkowicz, H Wang, ...
The British Journal of Radiology 92 (1102), 20190271, 2019
482019
Germline polymorphisms and length of survival of nasopharyngeal carcinoma: an exome‐wide association study in multiple cohorts
YM Guo, JR Chen, YC Feng, MLK Chua, Y Zeng, EP Hui, AKC Chan, ...
Advanced Science 7 (10), 1903727, 2020
142020
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis
LMH Schack, E Naderi, L Fachal, L Dorling, C Luccarini, AM Dunning, ...
British journal of cancer 126 (7), 1082-1090, 2022
132022
Asia-Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis. Best practices on …
CJ Ooi, I Hilmi, R Banerjee, SW Chuah, SC Ng, SC Wei, GK Makharia, ...
Intest Res 17, 285-310, 2019
132019
Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
L Huang, AYL Sim, Y Wu, Z Liang, K Li, Y Du, EHW Ong, HQ Tan, ...
Therapeutic Advances in Medical Oncology 12, 1758835920970050, 2020
122020
Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
FP Chen, L Lin, JH Liang, SH Tan, EHW Ong, YS Luo, L Huang, AYL Sim, ...
Therapeutic Advances in Medical Oncology 13, 17588359211052417, 2021
82021
High-dimensional characterization of the systemic immune landscape informs on synergism between radiation therapy and immune checkpoint blockade
KLM Chua, M Fehlings, ELL Yeo, A Nardin, H Sumatoh, PL Chu, W Nei, ...
International Journal of Radiation Oncology* Biology* Physics 108 (1), 70-80, 2020
62020
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
E Naderi, LMH Schack, C Welsh, AYL Sim, ME Aguado-Barrera, ...
Radiotherapy and Oncology 176, 138-148, 2022
52022
Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia
JSH Tan, JYH Teh, LLY Tan, SXF Tan, YQ Li, TWK Tan, MLC Wang, ...
Asia‐Pacific Journal of Clinical Oncology 18 (5), e346-e355, 2022
42022
A multicenter prospective observational study of nutritional status on survival in locally advanced nasopharynx cancer treated by induction chemotherapy and chemoradiotherapy.
J Miao, L Wang, C Hu, S Lin, SH Tan, E Ong, X Chen, Y Chen, Y Zhong, ...
Journal of Clinical Oncology 37 (15_suppl), 6036-6036, 2019
42019
Comparative genomic analyses between Asian and Caucasian prostate cancers in an 80,829 patient cohort.
A Sim Yen Ling, AK Hakansson, EHW Ong, ASY Lau, KP Low, TR Wong, ...
Journal of Clinical Oncology 40 (6_suppl), 273-273, 2022
32022
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction …
KLM Chua, ELL Yeo, WA Shihabudeen, SH Tan, TT Shwe, EHW Ong, ...
BMC cancer 18, 1-11, 2018
32018
Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
JSH Tan, TKY Tay, EHW Ong, M Fehlings, DSW Tan, NB Sukma, ...
European Thyroid Journal 13 (1), 2024
2024
Whole-Exome Sequencing Association Study Implicates Genetic Effects on Viral Oncogenesis and Tumor Microenvironment in Nasopharyngeal Carcinoma
Y Zeng, CL Luo, GW Lin, F Li, X Bai, JMY Ko, Y Liu, S He, JX Jiang, ...
medRxiv, 2023.10. 18.23297131, 2023
2023
Large-Scale Whole-Exome Sequencing Association Study Implicates Genetic Effects on Multiple Cell Types and EBV in Nasopharyngeal Carcinoma
Y Zeng, C Luo, G Lin, F Li, X Bai, JM Ko, Y Liu, S He, J Jiang, ONG EHW, ...
2023
Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer
T Zhang, Y Wei, BH Hong, T Sumiyoshi, EHW Ong, H Zeng, Y Li, CF Ng, ...
Clinical and Translational Medicine 13 (9), 2023
2023
Association of Claudin-1 overexpression with immune exclusion in nasopharyngeal carcinoma and its potential as a novel therapeutic target.
ELL Yeo, E Ong, J Neo, WM Chow, KM Tan, JSH Tan, JPS Yeong, ...
JCO Global Oncology 9 (Supplement_1), 151-151, 2023
2023
DNA damage response (DDR) variants and effects on the tumor transcriptome and microenvironment in east Asian (EA) prostate cancers (PCa).
BH Hong, AK Hakansson, E Ong, WM Chow, KJ Tay, JKL Tuan, ...
JCO Global Oncology 9 (Supplement_1), 75-75, 2023
2023
227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse
J Neo, E Ong, A Sim, JJ Miao, JTS Wee, KW Fong, YL Soong, SY Sin, ...
Annals of Oncology 33, S1523, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20